Kataoka, H., Kodama, F., Tomita, T., Kondo, M., Nagasaka, A., Nishikawa, S., & Mukai, M. (2021). Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab. Internal Medicine, 60(4), 639-643. https://doi.org/10.2169/internalmedicine.6010-20
Chicago Style (17th ed.) CitationKataoka, Hiroshi, Fumihiro Kodama, Tomoko Tomita, Makoto Kondo, Atsushi Nagasaka, Shuji Nishikawa, and Masaya Mukai. "Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab." Internal Medicine 60, no. 4 (2021): 639-643. https://doi.org/10.2169/internalmedicine.6010-20.
MLA (9th ed.) CitationKataoka, Hiroshi, et al. "Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab." Internal Medicine, vol. 60, no. 4, 2021, pp. 639-643, https://doi.org/10.2169/internalmedicine.6010-20.